Tech Company Financing Transactions
Ophelia Funding Round
Ophelia closed a $50 million Series B investment round on 12/16/2021. Investors included Tiger Global Management, 640 Oxford Ventures and Allbirds.
Transaction Overview
Company Name
Announced On
12/16/2021
Transaction Type
Venture Equity
Amount
$50,000,000
Round
Series B
Investors
Tiger Global Management (Lead Investor) (Jay Chen)
private investors (Elliot Cohen)
Proceeds Purpose
The funding will enable Ophelia to expand its treatment program to more patients and clinicians across the United States, integrate with additional payors and partners, and develop its clinician recruitment, training, and support platform.
Company Information
Company Status
Private & Independent
Industry
Healthcare Services
Mailing Address
228 Park Ave. S 15314
New York, NY 10003
USA
New York, NY 10003
USA
Phone
Website
Email Address
Overview
We're a diverse collective of hearts and minds - healthcare providers, scientists, techies, and citizens - on a mission to offer the best of medicine without the baggage of rehab. Our mission is to reinvent the drug rehab model - to replace folklore with science, drug dealers with doctors, and stigma with privacy, convenience, and choice.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Zack Gray
Chief Medical Officer
Arthur Williams
Chief Operating Officer
Mattan Griffel
VP - Bus. Development
Darshak Sanghavi
VP - Engineering
Ryan Greenberg
VP - Operations
Kathleen Balakier
Browse more venture capital transactions:
Prev: 12/16/2021: Forethought venture capital transaction
Next: 12/16/2021: Papaya Payments venture capital transaction
Share this article
News on VC Transactions
We do our best to report on funding rounds that are announced publicly. VC investment data records reported here are sourced from publicly available VC deal announcements. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs